Monte Rosa Therapeutics, Inc. (GLUE)
9.31
-1.00
(-9.70%)
USD |
NASDAQ |
Nov 12, 16:00
9.50
+0.19
(+2.04%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Liabilities (Quarterly) : 201.52M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 201.52M |
| June 30, 2026 | 203.88M |
| March 31, 2026 | 214.51M |
| December 31, 2025 | 215.60M |
| September 30, 2025 | 214.00M |
| June 30, 2025 | 91.51M |
| March 31, 2025 | 118.04M |
| December 31, 2024 | 215.80M |
| September 30, 2024 | 109.62M |
| June 30, 2024 | 119.44M |
| March 31, 2024 | 114.23M |
| December 31, 2023 | 124.50M |
| Date | Value |
|---|---|
| September 30, 2023 | 67.58M |
| June 30, 2023 | 64.96M |
| March 31, 2023 | 65.30M |
| December 31, 2022 | 70.98M |
| September 30, 2022 | 66.51M |
| June 30, 2022 | 63.01M |
| March 31, 2022 | 20.13M |
| December 31, 2021 | 18.81M |
| September 30, 2021 | 14.74M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 241.22M |
| December 31, 2020 | 98.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp. | 758.10M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.08M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 697.72M |
| Shareholders Equity (Quarterly) | 496.21M |
| Debt to Equity Ratio | 0.0731 |
| Current Ratio | 10.32 |
| Net Debt Paydown Yield | 0.10% |